MedTrace Logo

SB-705498 Dental Pain Study After Tooth Extraction

NCT00281684 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 145

Last updated 2019-01-28

Study results available
· View outcomes & findings →

Summary

This clinical trial is a multi centre, randomised, single-blind, parallel group, placebo-controlled, single oral dose study with a positive control arm. Patients previously scheduled for 3rd molar tooth extraction, who are otherwise healthy, will be recruited. Upon completion of surgery, e.g. prior to established pain, patients will be randomised to treatment (SB-706598, placebo or co-codamol) and dosed with the study medication

Conditions

  • Toothache

Interventions

DRUG

SB705498 400 mg

SB705498 400 mg

DRUG

SB705498 1000 mg

SB705498 1000 mg

DRUG

Placebo

Placebo

DRUG

Co-Codamol

Co-Codamol

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-07
Primary Completion
2007-10-03
Completion
2007-10-03

Countries

  • Italy
  • South Korea
  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00281684 on ClinicalTrials.gov